Senior insider sale
Chief Operating Officer at VIRIDIAN THERAPEUTICS, INC.\DE — senior position signals high conviction
$92.0K
3.05K shares
What this filing means
BEETHAM THOMAS W. plans to sell 3.05K shares of VIRIDIAN THERAPEUTICS, INC.\DE valued at approximately $92.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001959173-26-001932
Officer· Chief Operating Officer
Since Mar 2026
3.05K
Shares to sell
$92.0K
Approx. market value
3.05K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/3/2026
3.05KTotal acquired3.05K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2026 | Restricted Stock Vesting Compensation | 3.05K | — |
| Total | 3.05K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.05K
Market value
$92.0K
3/4/2026
Total
Units
3.05K
Value
$92.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/4/2026 | 3.05K | $92.0K | NASDAQ | Planned |
| Total | 3.05K | $92.0K | ||